The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy.
Arora
Mandeep Kumar
MK
Cardiovascular Pharmacology Division, ISF College of Pharmacy, Moga 142 001, Punjab, India.
Reddy
Krishna
K
Balakumar
Pitchai
P